Literature DB >> 19875982

Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Cintia Roodveldt1, Carlos W Bertoncini, August Andersson, Annemieke T van der Goot, Shang-Te Hsu, Rafael Fernández-Montesinos, Jannie de Jong, Tjakko J van Ham, Ellen A Nollen, David Pozo, John Christodoulou, Christopher M Dobson.   

Abstract

The ATP-dependent protein chaperone heat-shock protein 70 (Hsp70) displays broad anti-aggregation functions and has a critical function in preventing protein misfolding pathologies. According to in vitro and in vivo models of Parkinson's disease (PD), loss of Hsp70 activity is associated with neurodegeneration and the formation of amyloid deposits of alpha-synuclein (alphaSyn), which constitute the intraneuronal inclusions in PD patients known as Lewy bodies. Here, we show that Hsp70 depletion can be a direct result of the presence of aggregation-prone polypeptides. We show a nucleotide-dependent interaction between Hsp70 and alphaSyn, which leads to the aggregation of Hsp70, in the presence of ADP along with alphaSyn. Such a co-aggregation phenomenon can be prevented in vitro by the co-chaperone Hip (ST13), and the hypothesis that it might do so also in vivo is supported by studies of a Caenorhabditis elegans model of alphaSyn aggregation. Our findings indicate that a decreased expression of Hip could facilitate depletion of Hsp70 by amyloidogenic polypeptides, impairing chaperone proteostasis and stimulating neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875982      PMCID: PMC2790486          DOI: 10.1038/emboj.2009.298

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

Review 1.  Modulation of neurodegeneration by molecular chaperones.

Authors:  Paul J Muchowski; Jennifer L Wacker
Journal:  Nat Rev Neurosci       Date:  2005-01       Impact factor: 34.870

2.  Maintenance of structure and function of mitochondrial Hsp70 chaperones requires the chaperone Hep1.

Authors:  Martin Sichting; Dejana Mokranjac; Abdussalam Azem; Walter Neupert; Kai Hell
Journal:  EMBO J       Date:  2005-02-17       Impact factor: 11.598

Review 3.  Molecular chaperones in cellular protein folding.

Authors:  F U Hartl
Journal:  Nature       Date:  1996-06-13       Impact factor: 49.962

Review 4.  The Hsp70 and Hsp60 chaperone machines.

Authors:  B Bukau; A L Horwich
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

Review 5.  Interaction of Hsp70 chaperones with substrates.

Authors:  S Rüdiger; A Buchberger; B Bukau
Journal:  Nat Struct Biol       Date:  1997-05

6.  Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.

Authors:  Angelo Demuro; Erene Mina; Rakez Kayed; Saskia C Milton; Ian Parker; Charles G Glabe
Journal:  J Biol Chem       Date:  2005-02-17       Impact factor: 5.157

7.  Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species.

Authors:  Matthew M Dedmon; John Christodoulou; Mark R Wilson; Christopher M Dobson
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

8.  Regulation of the heat-shock protein 70 reaction cycle by the mammalian DnaJ homolog, Hsp40.

Authors:  Y Minami; J Höhfeld; K Ohtsuka; F U Hartl
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

Review 9.  Hsp70 chaperones: cellular functions and molecular mechanism.

Authors:  M P Mayer; B Bukau
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

10.  Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer.

Authors:  Jennifer L Wacker; M Hadi Zareie; Hanson Fong; Mehmet Sarikaya; Paul J Muchowski
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

View more
  57 in total

1.  Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins.

Authors:  Pietro Sormanni; Francesco A Aprile; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 2.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  Structure and function of Hip, an attenuator of the Hsp70 chaperone cycle.

Authors:  Zhuo Li; F Ulrich Hartl; Andreas Bracher
Journal:  Nat Struct Mol Biol       Date:  2013-06-30       Impact factor: 15.369

4.  Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein.

Authors:  Santiago Esteban-Martín; Jordi Silvestre-Ryan; Carlos W Bertoncini; Xavier Salvatella
Journal:  Biophys J       Date:  2013-09-03       Impact factor: 4.033

Review 5.  Chaperone networks: tipping the balance in protein folding diseases.

Authors:  Cindy Voisine; Jesper Søndergaard Pedersen; Richard I Morimoto
Journal:  Neurobiol Dis       Date:  2010-05-21       Impact factor: 5.996

Review 6.  Age-related neurodegenerative diseases.

Authors:  Michael Duggan; Bahareh Torkzaban; Taha Mohseni Ahooyi; Kamel Khalili; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2019-09-25       Impact factor: 6.384

Review 7.  Watching worms whither: modeling neurodegeneration in C. elegans.

Authors:  Benjamin Wolozin; Christopher Gabel; Andrew Ferree; Maria Guillily; Atsushi Ebata
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 8.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.

Authors:  Sandeep K Sharma; Smriti Priya
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

10.  Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.

Authors:  Virginie Redeker; Samantha Pemberton; Willy Bienvenut; Luc Bousset; Ronald Melki
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.